Highest paid med tech CEOs of 2015

Med tech CEOs made out okay in 2015. Altogether, CEOs from top companies got more than $180 million in pay last year.

Few could match Medtronic CEO Omar Ishrak’s paycheck. The med tech helmsman got a whopping $39.4 million in pay following the company’s deal with Covidien. Ishrak pledged more R&D after the deal close, and has already steered Medtronic ($MDT) toward expansion on the R&D front in areas including robotics and TAVR.

Johnson & Johnson CEO Alex Gorsky’s pay decreased slightly last year to $23.7 million from $24.9 million. The change reflects a slow year for the company’s ($JNJ) device business, which charted less-than-stellar sales in 2015.

Gorsky said that the company is on track to improvement, though. Earlier this year, the CEO announced sweeping changes that could help J&J’s device unit save up to $1 billion in costs by 2018.

Here’s the rundown of what the med tech industry’s top brass made in 2015. As always, feel free to contact us with any comments or questions.

Suggested Articles

Working with a joint venture established by BMS and Pfizer, Fitbit also plans to help develop educational content regarding atrial fibrillation.

Plexium is launching with $28 million to build its platform and a pipeline of drugs that target the enzymes drive recognition of protein targets.

The lackluster results led Syros to switch its attention to an oral CDK7 inhibitor, SY-5609, that is due to enter the clinic early next year.